ASAM
Opioid use disorder
National Practice Guideline and supporting resources for the treatment of opioid use disorder.
Explore the ASAM guideline ↗
A Chapter of ASAM
Florida Society of Addiction Medicine
Clinical Resources
Trusted guidance. Practical tools.
Official resources for addiction medicine, overdose prevention and prescribing in Florida.
01 · Evidence & practice
Treatment guidance
Clinical guidelines and implementation resources from ASAM and CDC.
CDC
OUD treatment overview
A clinician-facing overview of treatment for opioid use disorder, including medications and related care resources.
Read the CDC overview ↗ASAM
Alcohol withdrawal management
Guideline resources for alcohol withdrawal management in ambulatory and inpatient settings.
View the withdrawal guideline ↗ASAM / AAAP
Stimulant use disorder
Clinical practice guideline resources addressing stimulant use disorder, intoxication and withdrawal.
View the stimulant guideline ↗ASAM & PARTNER SOCIETIES
Benzodiazepine tapering
Joint clinical practice guideline and supporting tools for benzodiazepine tapering.
View the tapering resources ↗02 · Prevention & response
Overdose prevention
Practical education and Florida resources from public health agencies.
CDC
Naloxone resources
Educational materials and tools for clinicians discussing naloxone and opioid overdose prevention.
Open the naloxone toolkit ↗FLORIDA DCF
Florida overdose prevention
Florida Department of Children and Families information on overdose prevention programs and resources.
Explore Florida resources ↗03 · Florida & federal requirements
Florida prescribing resources
Direct links to official programs, statutes and federal prescribing information. Confirm requirements with the issuing authority.
FLORIDA DEPARTMENT OF HEALTH
E-FORCSE® / PDMP
Florida’s Prescription Drug Monitoring Program: program information, registration and practitioner resources.
Visit the Florida PDMP ↗FLORIDA LEGISLATURE
Prescription monitoring statute
Section 893.055, Florida Statutes, covering Florida’s prescription drug monitoring program.
Read section 893.055 ↗FLORIDA LEGISLATURE
Controlled substance prescribing
Section 456.44, Florida Statutes, addressing controlled substance prescribing. Consult the full current text and applicable rules.
Read section 456.44 ↗U.S. DRUG ENFORCEMENT ADMINISTRATION
Buprenorphine prescribing FAQ
DEA’s official frequently asked questions about buprenorphine prescribing and federal registration requirements.
Read the DEA FAQ ↗U.S. DRUG ENFORCEMENT ADMINISTRATION
MATE Act training FAQ
DEA information about the substance use disorder training requirement for controlled substance prescribers.
Read the MATE Act FAQ ↗Looking for learning opportunities? Explore FSAM education & events →
Let's stay connected
Valentino Norton
FSAM Administrator
Questions about membership, education or getting involved? Contact Valentino.